NASDAQ · Biotechnology
Skye Bioscience, Inc. Common Stock (SKYE)
$0.70
-11.03%
32
In band
Moving averages
SMA 200$4.86-85.60%
Company profile
Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes therapeutic drugs that modulate the endocannabinoid system. The company is headquartered in San Diego, California.
SectorHealthcare
IndustryBiotechnology
Market cap$5.67M
P/E ratioNone
EPS$-10.16
Beta2.859
Dividend yield0.00%
52-week high$2.25
52-week low$0.26
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
ACXP
Acurx Pharmaceuticals Inc
RSI 45
SNGX
Soligenix Inc
RSI 21
IMNN
Imunon Inc
RSI 25
PHIO
Phio Pharmaceuticals Corp
RSI 28
BCDA
BioCardia Inc
RSI 34
KTTA
Pasithea Therapeutics Corp
RSI 53
RSI alerts for SKYE
An email when SKYE closes below RSI 30 or above 70. Nothing else.
Data last updated 31 October 2026 at 8:38 PM EDT